| 摘要 |
FIELD: pharmaceutical industry, in particular treatment and prophylaxis of oncology diseases. ^ SUBSTANCE: claimed agent is based on flavolignans selected from silimarin isomers and phospholipids, wherein as silimarin isomers extract from Solybum marianum fruits in liposome form with particle size of 100-500 nm, containing not less than 10 % of extract from Solybum marianum fruits is used. Method for treatment and prophylaxis of oncology diseases includes administration of said agent to patient by injection or infusion. ^ EFFECT: agent having low biodegradability and high selectivity for effective treatment and prophylaxis of estrogen-dependent tumors and epidermal and mesenchyme origin tumors. ^ 7 cl, 4 tbl, 4 ex |
